Huaren Pharmaceutical Co., Ltd. (SHE:300110)
China flag China · Delayed Price · Currency is CNY
2.880
-0.060 (-2.04%)
May 21, 2026, 3:04 PM CST

Huaren Pharmaceutical Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
3,4053,7244,1614,9895,0135,675
Market Cap Growth
-3.03%-10.51%-16.59%-0.47%-11.67%1.48%
Enterprise Value
4,1944,4255,1006,1926,6797,116
Last Close Price
2.883.153.524.194.194.72
PE Ratio
---26.5327.7343.52
Forward PE
-41.1841.1841.1841.1841.18
PS Ratio
2.562.823.083.053.103.64
PB Ratio
3.684.103.031.801.932.32
P/TBV Ratio
9.2710.7715.623.213.654.82
P/FCF Ratio
12.1710.9113.9819.2128.54-
P/OCF Ratio
11.069.5412.9116.3323.00-
EV/Sales Ratio
3.163.353.773.784.124.56
EV/EBITDA Ratio
18.5919.4020.5713.1516.9919.71
EV/EBIT Ratio
34.6136.4739.2217.9527.3131.40
EV/FCF Ratio
14.9912.9717.1423.8438.03-
Debt / Equity Ratio
0.981.020.930.560.640.75
Debt / EBITDA Ratio
4.004.075.143.324.245.09
Debt / FCF Ratio
3.232.734.296.029.52-
Net Debt / Equity Ratio
0.770.870.810.480.560.58
Net Debt / EBITDA Ratio
3.183.474.492.833.693.94
Net Debt / FCF Ratio
2.562.323.745.138.25-2.35
Asset Turnover
0.430.430.320.320.300.35
Inventory Turnover
3.333.092.713.133.413.00
Quick Ratio
0.590.490.541.581.181.05
Current Ratio
0.820.670.771.841.351.20
Return on Equity (ROE)
-39.64%-40.24%-65.84%7.21%7.19%5.62%
Return on Assets (ROA)
2.43%2.47%1.89%4.17%2.83%3.13%
Return on Invested Capital (ROIC)
7.25%5.79%3.95%7.10%5.44%6.22%
Return on Capital Employed (ROCE)
8.40%9.90%6.90%9.40%7.80%7.40%
Earnings Yield
-13.60%-12.43%-32.88%3.77%3.61%2.30%
FCF Yield
8.22%9.16%7.15%5.21%3.50%-10.69%
Dividend Yield
---0.50%0.50%0.38%
Payout Ratio
---45.81%49.44%54.73%
Buyback Yield / Dilution
-0.14%0.01%-0.01%-0.04%0.33%-0.23%
Total Shareholder Return
-0.14%0.01%-0.01%0.46%0.83%0.15%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.